Combined systemic immune-inflammatory index and prognostic nutritional index predicts the efficacy and prognosis of ES-SCLC patients receiving PD-L1 inhibitors combined with first-line chemotherapy
The baseline SII-PNI score can serve as a reliable prognostic indicator for ES-SCLC patients receiving immunotherapy. Higher SII-PNI scores imply a worse prognosis.
Authors
- Yanwei Su (ORCID: https://orcid.org/0000-0002-9339-092X)
- Yi Ge (ORCID: https://orcid.org/0009-0005-9193-7134)
- Liping Wang (ORCID: https://orcid.org/0000-0002-6771-6498)
- Xiaoyu Liu (ORCID: https://orcid.org/0000-0001-9888-5836)
- Yixin Li (ORCID: https://orcid.org/0000-0003-0733-9237)
- Yishi Xu
Institutions
- Luohe Medical College (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-12-04
- DOI
- https://doi.org/10.3389/fonc.2024.1485849
- Citations
- 6
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.70